Becton, Dickinson and Company (BDX): A Healthcare Leader Among Cheap Dividend Stocks

Becton, Dickinson and Company (NYSE:BDX) is included among the 13 Incredibly Cheap Dividend Stocks to Invest in.

Becton, Dickinson and Company (NYSE:BDX), which positions itself as a medical technology company, is currently undergoing a turnaround. The business has faced challenges in recent years, including several strategic missteps and a large product recall.

More recently, Becton, Dickinson and Company (NYSE:BDX) has taken steps to reshape its operations. The company acquired the critical care product group from Edwards Lifesciences to strengthen its core business and announced plans to spin off its biosciences and diagnostic solutions division. That division is set to be purchased by Waters in a complex deal that is not expected to close until 2026.

Despite these transitions, Becton, Dickinson and Company (NYSE:BDX)’s strong dividend record may appeal to more risk-tolerant investors. The planned spinoff is projected to be accretive to earnings in its first year, which indicates that the dividend should remain intact through the process.

Becton, Dickinson and Company (NYSE:BDX) holds a 53-year track record of consistent dividend payments, which makes it one of the best dividend stocks to invest in. The company’s quarterly dividend comes in at $1.04 per share and has a dividend yield of 2.22%, as of September 19.

While we acknowledge the potential of BDX as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.

READ NEXT: 13 Best High Dividend Stocks to Buy Under $100 and Dividend Stock Portfolio For Income: 12 Stocks to Buy Now.

Disclosure: None.